The Atlantic will convene top health policy thinkers and practitioners to explore how to foster drug innovation while controlling cost with new approaches like value-based programs on the horizon.
The Atlantic is co-presenting three events this fall with Editor in Chief Jeffrey Goldberg and National Correspondent Ta-Nehisi Coates to discuss his new book.
The Atlantic convened key stakeholders to discuss the state of and future for biosimilars.
Graham Allison, Director of Harvard University's Belfer Center for Science and International Affairs, and author of Destined for War: Can America and China Escape Thucydides’s Trap?, joined The Atlantic’s Editor in Chief Jeffrey Goldberg to explore the US-China relationship and see how war in East Asia can be avoided.
The Atlantic gathered business and higher education leaders and public officials to examine the way data is changing what employers look for in graduates, how academic institutions teach data science to their students and what these trends mean for the economy of the future.
The Atlantic gathered key stakeholders to examine the future for biosimilars domestically and abroad.
In a series of conversations, The Atlantic will explore civitas, the contract binding all citizens together.
The Atlantic’s David Frum joined Scott Stossel to discuss why he believes President Trump could lead our democracy to an autocracy, and what it could mean for the future of the Republic.